Core Viewpoint - Supreme is strategically acquiring SlimFast to leverage the growing demand for GLP-1 weight-loss drugs, positioning itself to enhance its product offerings in the nutrition and wellness sector [1][7]. Group 1: Acquisition Details - Supreme is purchasing SlimFast assets in the UK, Ireland, and Europe from Glanbia for approximately £27 million ($36.2 million) [2]. - The deal includes a deferred payment of $9 million to be made within the next 15 months, bringing the total transaction value to £20.1 million [4]. - Glanbia previously sold SlimFast's North American assets to Heartland Food Products Group, with the financial terms of that deal undisclosed [3]. Group 2: Financial Performance - SlimFast's UK and European assets generated revenue of £25.5 million and an adjusted gross profit of £9.7 million for the year ending December 2024 [5]. Group 3: Market Expansion Opportunities - The acquisition provides Supreme with upsell opportunities across approximately 55,000 retailers, including cash-and-carry, B2C e-commerce, and convenience outlets that currently do not stock SlimFast products [6]. - Supreme plans to explore international market expansion for SlimFast, excluding the Americas, Australasia, the Caribbean, and the Philippines [6]. Group 4: Strategic Fit - Supreme's CEO emphasized that SlimFast is a complementary addition to the company's existing drinks and wellness category, highlighting the potential for product innovation and market presence enhancement [7].